Document is current

Article History

Received: 20 October 2025

Accepted: 19 January 2026

First Online: 2 February 2026

Declarations

:

: Joana Nicolau has no conflict of interest to declare. Anna López-Ferrer is an Editorial Board member of Dermatology and Therapy . Anna López-Ferrer was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Anna López-Ferrer has received grants/research supports or participation in clinical trials (paid to Institution) from Abbvie, Almirall, Alumis, Amgen, Boehringer Ingelheim, J&J Innovative Medicine, Leo-Pharma, Lilly, Novartis, Takeda, UCB and has received honoraria or consultation fees (paid to herself) from AbbVie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Myers-Squibb, Galenicum, J&J Innovative Medicine, Leo-Pharma, Lilly, Novartis and UCB. Pablo de la Cueva has participated as Consultant, advisory board member, and has received honorary for speaking and participation in clinical trials with the following pharmaceutical companies: Abbvie, Almirall, Astellas, Biogen, Boehringer, Celgene, Janssen, LEO Pharma, Lilly, MSD, Novartis,Pfizer, Roche, Sanofi, Takeda and UCB.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.